Your browser doesn't support javascript.
loading
Mendelian randomisation study for statin treatment - Authors' reply.
Swerdlow, Daniel I; Preiss, David; Hingorani, Aroon D; Sattar, Naveed.
Affiliation
  • Swerdlow DI; Institute of Cardiovascular Science, University College London, London NW1 2DA, UK. Electronic address: d.swerdlow@ucl.ac.uk.
  • Preiss D; BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
  • Hingorani AD; Institute of Cardiovascular Science, University College London, London NW1 2DA, UK.
  • Sattar N; BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Lancet ; 385(9981): 1946, 2015 May 16.
Article in En | MEDLINE | ID: mdl-26090640
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Body Weight / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Polymorphism, Single Nucleotide / Diabetes Mellitus, Type 2 / Hydroxymethylglutaryl CoA Reductases Type of study: Clinical_trials Limits: Female / Humans / Male Language: En Journal: Lancet Year: 2015 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Body Weight / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Polymorphism, Single Nucleotide / Diabetes Mellitus, Type 2 / Hydroxymethylglutaryl CoA Reductases Type of study: Clinical_trials Limits: Female / Humans / Male Language: En Journal: Lancet Year: 2015 Document type: Article